Patents by Inventor H. Lundbeck A/S

H. Lundbeck A/S has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RADIOLABELLED PHENYLIMIDAZOLE-BASED LIGANDS
    Publication number: 20130303770
    Abstract: The present invention relates to radiolabelled PDE10A ligands which are useful for imaging and quantifying the PDE10A enzyme using positron emission tomography (PET).
    Type: Application
    Filed: November 10, 2011
    Publication date: November 14, 2013
    Applicant: H. Lundbeck A/S
    Inventor: H. Lundbeck A/S
  • CRYSTALLINE FORMS OF 4-[2-(4-METHYLPHENYLSULFANYL)-PHENYL] PIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20130190352
    Abstract: Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine and salts thereof are provided e.g. for the treatment of neuropathic pain.
    Type: Application
    Filed: October 25, 2012
    Publication date: July 25, 2013
    Applicant: H. LUNDBECK A/S
    Inventor: H. LUNDBECK A/S
  • ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME
    Publication number: 20130184277
    Abstract: The present invention provides adamantyl diamide derivatives of formula (I): wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
    Type: Application
    Filed: February 1, 2013
    Publication date: July 18, 2013
    Applicant: H. Lundbeck A/S
    Inventor: H. Lundbeck A/S
  • Heteroaryl amide derivatives
    Publication number: 20130172549
    Abstract: Heteroaryl amide derivatives are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
    Type: Application
    Filed: January 29, 2013
    Publication date: July 4, 2013
    Applicant: H. Lundbeck A/S
    Inventor: H. Lundbeck A/S